| Application no. and date | 10782039.1 (espacenet) (Federated) (European Patent Register), 20101027 | | Patent/reg. no. and date | DK/EP 2493466, 20210310 | | Publication date | 20120905 | | Priority no. and date | US 256160 P, 20091029, US 293903 P, 20100111, US 355834 P, 20100617, US 355888 P, 20100617, US 369929 P, 20100802, US 383933 P, 20100917, US 389969 P, 20101005 | | EP pub. no. and date |
EP 2493466 20120905 | | Effective date | | | Applicant/owner | Sanofi, 46 Avenue de la Grande Armée
75017 Paris, FR | | Applicant ref. no. | V52703DK00 | | Inventor | GUPTA, Sunil, c/o Sanofi-Aventis US. Inc.
1041 Routes 202-206 Mail Code: D-303A
Bridgewater, New Jersey 08807, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/164 (2006.01) , A61K 31/56 (2006.01) , A61K 45/06 (2006.01) , A61P 35/00 (2006.01) | | Title | Hidtil ukendt antitumoral anvendelse af cabazitaxel | | Int. application no. | IB2010054866 | | Int. publication no. | WO2011051894 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
